Key immune cell may play role in lung cancer susceptibility

by Caroline Arbanas

(Medical Xpress)—Why do many heavy smokers evade lung cancer while others who have never lit up die of the disease? The question has vexed scientists for decades.

Now, new research at Washington University School of Medicine in St. Louis suggests a key immune cell may play a role in lung cancer susceptibility. Working in mice, they found evidence that the in , which typically seek out and destroy tumor cells, contributes to whether or not the animals develop lung cancer.

The research is published in September in .

"Overall, humans are genetically very similar but their immune systems are incredibly diverse," explains senior author Alexander Krupnick, MD, a thoracic surgeon at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. "Our findings add to the growing body of evidence suggesting that innate differences in immunity may determine not only a person's susceptibility to colds but also to lung cancer."
Based on the findings in mice, Krupnick says he and his colleagues now are studying whether humans have a similar genetic diversity in their cells. As part of a new clinical study, they're analyzing the blood of heavy smokers with and without lung cancer and never-smokers with and without lung cancer to look for differences.

"We want to know whether who don't get lung cancer have natural killer cells that are somehow better at destroying newly developing ," says Krupnick, associate professor of surgery. "And, by comparison, do patients who have never smoked but develop lung cancer have weak natural killer cells?"

For the mouse study, the scientists evaluated three groups of mice with varying susceptibilities to . After the mice were exposed to a carcinogen that causes lung cancer, one group readily developed the disease while another showed little evidence of the tumors. A third group experienced moderate tumor growth.

When the researchers depleted natural killers cells from the mice using an antibody, those that had been resistant to lung cancer developed large, aggressive tumors.

Further, in mice susceptible to lung cancer, the scientists showed that manipulating the immune system with a bone marrow transplant could significantly block the development of lung cancer. Their studies indicate that natural killer cells, not other types of like T cells or inflammatory cells, are responsible for this phenomenon.

In other types of cancers, including those of the breast, colon and prostate, T cells are capable of destroying . But in lung cancer, scientists suspect that T cells become inactivated, which may give natural killer cells a more prominent role.

The researchers also traced the genetic diversity of the natural killer cells in the mice to a region of chromosome 6, which includes numerous genes that influence the effectiveness of these cells.

Moving forward, Krupnick and his team want to learn whether natural killer cells influence lung cancer susceptibility in people. "We need to identify those patients who are resistant to lung cancer and ask, 'What is unique about their natural killer cells – are they more potent or do they produce more of them than people with ?' The answer will determine our next steps."

More information: Kreisel D, Gelman AE, Higashikubo R, Lin X, Vikis HG, White JM, Toth KA, Deshpande C, Carreno BM, You M, Taffner SM, Yokoyama WM, Bui JD, Schreiber RD, Krupnick AS. Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer. Cancer Research. September 2012.

Related Stories

Researchers develop new method to test for lung cancer

Apr 01, 2008

Researchers from Boston University School of Medicine have developed a new “clinicogenomic model” to accurately test for lung cancer. The model combines a specific gene expression for lung cancer as well as clinical ...

Recommended for you

Gene test aids cancer profile

8 hours ago

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

How a common antacid could lead to cheaper anti-cancer drugs

Nov 26, 2014

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.